In vivo immunomodulation by monoclonal anti-L3T4
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 106 (1) , 163-173
- https://doi.org/10.1016/0008-8749(87)90159-6
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Perturbation of the T4 molecule transmits a negative signal to T cells.The Journal of Experimental Medicine, 1985
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivityCellular Immunology, 1985
- Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.The Journal of Experimental Medicine, 1985
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- In vivo suppression of T‐dependent antibody responses by treatment with a monoclonal anti‐L3T4 antibodyEuropean Journal of Immunology, 1985
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- New concepts in immunotherapyImmunology Today, 1984
- Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen‐ReactivityImmunological Reviews, 1983
- ALTERATION OF LYMPHOID CELLS IN AKR MICE BY TREATMENT WITH MONOCLONAL ANTIBODY AGAINST THY-1 ANTIGENTransplantation, 1982